2019
DOI: 10.1155/2019/3565970
|View full text |Cite
|
Sign up to set email alerts
|

Proteomic Technology “Lens” for Epithelial-Mesenchymal Transition Process Identification in Oncology

Abstract: The epithelial-mesenchymal transition (EMT) is a complex transformation process that induces local and distant progression of many malignant tumours. Due to its complex array of proteins that are dynamically over-/underexpressed during this process, proteomic technologies gained their place in the EMT research in the last years. Proteomics has identified new molecular pathways of this process and brought important insights to develop new therapy targets. Various proteomic tools and multiple combinations were d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 129 publications
0
9
0
Order By: Relevance
“…Using proteomics, new molecular pathway related to this process has been identified including MAPK, PI3K/AKT, WNT pathways and Akt/mTOR signaling pathway, thus providing critical insights into the development of novel therapeutic targets. 26,27 Recent studies have shown that EMT is associated with tumor cell migration and invasion, and cancer stem cell properties, including metastasis of glioma, human esophageal squamous cell carcinoma, and breast cancer. [28][29][30][31] And Recent evidence indicated that some lncRNAs could regulate the EMT process to promote tumor development, for example, LINC00460 silencing inhibited EMT in colon cancer via Upregulating miR-433-3p, 32 overexpression of GATA6 antisense RNA 1 (GATA6-AS1) Inhibited EMT through the Wnt/b-Catenin Signaling Pathway in GC, 33 CHRF promoted GC cell invasion and migration via regulating EMT.…”
Section: Discussionmentioning
confidence: 99%
“…Using proteomics, new molecular pathway related to this process has been identified including MAPK, PI3K/AKT, WNT pathways and Akt/mTOR signaling pathway, thus providing critical insights into the development of novel therapeutic targets. 26,27 Recent studies have shown that EMT is associated with tumor cell migration and invasion, and cancer stem cell properties, including metastasis of glioma, human esophageal squamous cell carcinoma, and breast cancer. [28][29][30][31] And Recent evidence indicated that some lncRNAs could regulate the EMT process to promote tumor development, for example, LINC00460 silencing inhibited EMT in colon cancer via Upregulating miR-433-3p, 32 overexpression of GATA6 antisense RNA 1 (GATA6-AS1) Inhibited EMT through the Wnt/b-Catenin Signaling Pathway in GC, 33 CHRF promoted GC cell invasion and migration via regulating EMT.…”
Section: Discussionmentioning
confidence: 99%
“…In the human body, MMPs are synthesized by numerous cellular types, such as fibroblasts, macrophages, endothelial cells, vascular smooth muscle, osteoblasts, etc. [ 12 , 13 ]. MMPs are grouped into several classes depending on the organization mode of their structural domains ( Table 1 ).…”
Section: Mmps As Molecular Promoters In Carcinogenesismentioning
confidence: 99%
“…The discovery of new substrates for MMPs offers novel perspectives on the role of MMPs in disease pathogenesis. MMPs are deeply involved in cell differentiation and proliferation, as well as in apoptosis, angiogenesis and the immune response [ 12 , 13 ].…”
Section: Mmps As Molecular Promoters In Carcinogenesismentioning
confidence: 99%
“…Like in other solid tumors, the melanoma tumor microenvironment has an important role in the tumorigenesis dynamics (Neagu et al, 2019a). The tumor microenvironment consists of cancer-associated fibroblasts (CAFs), tumorassociated macrophages (TAMs), endothelial cells, immune cells, and a myriad of molecules with different origins.…”
Section: Tumor Microenvironment Mirna Expression In Cutaneous Melanomamentioning
confidence: 99%